Back pain—acute or chronic—affects the lower spine, discs, or surrounding muscles. Causes range from muscle strain to degenerative disc disease or spinal stenosis. Treatment aims to relieve pain, restore function, and identify underlying pathology to prevent recurrence.
For acute back pain, rest combined with ice/heat, gentle movement, and NSAIDs (ibuprofen, naproxen) typically resolve symptoms within weeks. Physiotherapy strengthens core muscles and improves posture. For chronic pain, a structured exercise programme is essential; aerobic activity, stretching, and targeted strength training reduce recurrence. NSAIDs remain a mainstay, though long-term use requires monitoring. Muscle relaxants (e.g. diazepam) may help acutely but are not for extended use. Spinal injections—nerve-root blocks with corticosteroid or epidural corticosteroid injections—provide relief in radiculopathy or spinal stenosis, typically lasting weeks to months. Manipulation by a chiropractor or osteopath may benefit some with acute pain. Severe, progressive or neurologically compromising conditions (cauda equina, fracture, malignancy) require imaging and specialist referral. Surgery (discectomy, fusion, decompression) is reserved for specific pathology unresponsive to conservative care.
Acupuncture shows evidence for chronic back pain in meta-analyses; effects are modest and variable. Herbal remedies (devil's claw, arnica) have limited supporting data. Yoga and mindfulness-based stress reduction programmes improve pain and function in some patients. Manipulation and mobilisation by qualified practitioners may provide short-term benefit. TENS units offer temporary symptomatic relief. Spinal traction (cervical or lumbar) is controversial and lacks strong evidence. Prolotherapy (PRP-based) is emerging but evidence remains preliminary.
Regenerative approaches—including stem-cell therapy, platelet-rich plasma (PRP), and biological disc augmentation—are being investigated for degenerative disc disease and discogenic pain. Bone-marrow-derived mesenchymal stem cells may reduce inflammation in the intervertebral disc; several clinical trials are ongoing. These therapies remain investigational and are not standard practice. Candidacy depends on imaging findings and failure of conservative treatment. Explore regenerative options for back conditions and eligibility assessment if conservative approaches have plateaued.
| Option | Type | Evidence | Indicative cost | Invasiveness | Recovery |
|---|---|---|---|---|---|
| Rest, ice/heat & NSAIDs | Standard | Strong | €5–50 | Low | Acute pain 2–6 weeks |
| Physiotherapy & core strengthening | Standard | Strong | €50–100 per session | Low | Ongoing; 6–12 weeks improvement |
| Epidural corticosteroid injections | Standard | Moderate | €400–800 | Medium | Few days; effects 4–12 weeks |
| Nerve-root blocks | Standard | Moderate | €300–600 | Medium | Few days; effects weeks to months |
| Spinal fusion or discectomy | Standard | Moderate | €12,000–30,000 | High | 3–6 months; for specific indications |
| Acupuncture | Alternative | Moderate | €50–80 per session | Low | None; multiple sessions needed |
| Yoga & mindfulness | Alternative | Moderate | €10–50 per class | Low | Ongoing; 8 weeks for benefit |
| Stem-cell or PRP disc therapy | Regenerative | Investigational | €3,000–12,000 | Medium | 2–4 weeks; clinical trials ongoing |
Seek urgent imaging if you have progressive neurological signs (leg weakness, numbness, bowel/bladder changes), fever with pain, or history of cancer or trauma. For chronic pain unresponsive to 6–8 weeks of conservative care, imaging may help identify specific pathology and guide treatment.
Prolonged bed rest worsens outcomes. Brief rest (1–2 days) may provide comfort, but gentle movement and gradual return to activity are essential. Start physiotherapy early to prevent muscle atrophy and improve recovery.
Injections provide temporary relief—typically weeks to a few months—and are most effective combined with physiotherapy. They are a bridge to recovery or pain management, not a permanent fix. Repeated injections are sometimes needed, but long-term reliance suggests conservative approaches may need adjustment.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Educational overview of treatment options; not medical advice. Standard treatments reflect mainstream guidance; regenerative/stem-cell uses are largely investigational. Reviewed by the StemCellAtlas editorial team.
Medicina rigenerativa certificata GMP nel cuore dell'UE — da 3.000–8.000 €, una frazione dei prezzi USA o tedeschi. Protocolli personalizzati per pazienti da oltre 50 Paesi.
Valutazione medica gratuita